FDA authorizes a 2nd pill to treat COVID-19
![Merck](https://cdn.mos.cms.futurecdn.net/JkgqVSd6keU2yGT6hbRbx8-415-80.jpg)
Another pill to treat COVID-19 is on the way.
The Food and Drug Administration on Thursday granted emergency use authorization to a pill to treat COVID-19 from Merck for adults who are at high risk of severe disease and "for whom alternative COVID-19 treatment options authorized by the FDA are not accessible or clinically appropriate." Molnupiravir is intended to be taken within five days of the onset of symptoms.
The pill isn't authorized for patients younger than 18 because it "may affect bone and cartilage growth," and it isn't authorized "for initiation of treatment in patients hospitalized due to COVID-19 because benefit of treatment has not been observed in people when treatment started after hospitalization due to COVID-19," the FDA said. Merck previously said the pill cut the risk of hospitalization and death by 30 percent.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
![https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg](https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516-320-80.jpg)
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"Today's authorization provides an additional treatment option against the COVID-19 virus in the form of a pill that can be taken orally," FDA Center for Drug Evaluation and Research director Dr. Patrizia Cavazzoni said. "Molnupiravir is limited to situations where other FDA-authorized treatments for COVID-19 are inaccessible or are not clinically appropriate and will be a useful treatment option for some patients with COVID-19 at high risk of hospitalization or death."
This came a day after the FDA granted emergency use authorization to a COVID-19 pill from Pfizer, although the White House noted it will take months for it to become widely available. As with the Pfizer pill, the FDA stressed that neither of these treatments are substitutes for COVID-19 vaccines.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
'Solitude has become a notable, and worrisome, trend of our times'
Instant Opinion Opinion, comment and editorials of the day
By Anya Jaremko-Greenwold, The Week US Published
-
Blake Lively accuses rom-com costar of smear job
Speed Read The actor accused Justin Baldoni, her director and costar on "It Ends With Us," of sexual harassment and a revenge campaign
By Peter Weber, The Week US Published
-
Germany arrests anti-Islam Saudi in SUV attack
Speed Read The attack on a Christmas market in Magdeburg left five people dead and more than 200 wounded
By Peter Weber, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published